Form 8-K - Current report:
SEC Accession No. 0001125345-25-000094
Filing Date
2025-08-13
Accepted
2025-08-13 16:14:50
Documents
14
Period of Report
2025-08-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20250813.htm   iXBRL 8-K 37830
2 EX-99.1 exhibit99-1pressreleaseeri.htm EX-99.1 11406
6 GRAPHIC macrogenics20logo_jpgormata.jpg GRAPHIC 139164
  Complete submission text file 0001125345-25-000094.txt   362416

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20250813.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20250813_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20250813_pre.xml EX-101.PRE 12508
16 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20250813_htm.xml XML 2717
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 251211783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)